SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Next-Generation Sequencing (NGS) of two independent cohorts identifies eleven circulating miRNAs for diagnosis of NASH and fibrosis- Sven FrancqueView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017A precision medicine approach to comprehensive NAFLD diagnosis via metabolomics-based liquid biopsy- Pablo OrtizView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Future scenarios of algorithm building- Tom Travison, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Serum GP73 as a surrogate biomarker of significant liver fibrosis and cirrhosis in NAFLD- Fengmin LuView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Big data vs. the individual liver - regulatory perspective- Robert Schuck, PharmD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 201720_LeemingView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Novel multiparametric magnetic resonance elastography (MRE) protocol accurately predicts NAS score for NASH diagnosis- Alina AllenView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Principles of kinetic measures- Greg Everson, MD, FACPView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Breath tests- Shadab Siddiqui, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Transient elastography & other techniques- Raj Vuppalanchi, MBBSView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017A meta-analysis on repeatability of magnetic resonance elastography of liver- Suraj SeraiView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Hepatic proton density fat fraction correlates with histologic measures of steatosis and is responsive to change in those measures in a multi-center nonalcoholic steatohepatitis clinical trial- Michael MiddletonView Slideset
